{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:35:29Z","timestamp":1788093329684,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejpb.2025.114901","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:09:20Z","timestamp":1760400560000},"page":"114901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Improving prefilled syringe injectability: influences of critical component attributes and human factors"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-0381","authenticated-orcid":false,"given":"Yunyun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7706-9703","authenticated-orcid":false,"given":"Linke","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4228-9626","authenticated-orcid":false,"given":"Quanmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejpb.2025.114901_b0005","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/17425247.2014.923400","article-title":"Pre-filled syringe \u2013 a ready-to-use drug delivery system: a review","volume":"11","author":"Ingle MPASA, MS (Biotechnology)","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114901_b0010","first-page":"262","article-title":"US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives","volume":"4","author":"Wang","year":"2021","journal-title":"Antib Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114901_b0015","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2205540","article-title":"A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations","volume":"15","author":"Ghosh","year":"2023","journal-title":"MAbs"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114901_b0020","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.xphs.2023.12.022","article-title":"A review of recent FDA-approved biologic-device combination products","volume":"113","author":"Guo","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114901_b0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijpharm.2018.11.012","article-title":"Injectability as a function of viscosity and dosing materials for subcutaneous administration","volume":"554","author":"Watt","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114901_b0030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.xphs.2021.11.008","article-title":"Ongoing challenges to develop high concentration monoclonal antibody-based formulations for subcutaneous administration: quo Vadis?","volume":"111","author":"Jiskoot","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114901_b0035","doi-asserted-by":"crossref","unstructured":"Linke Wu, Hui Li, Yunyun Wang , Chengyu Liu , Zhixin Zhao , Guisheng Zhuang , Quanmin Chen, Weichang Zhou, Jeremy Guo. Advancing injection force modeling and viscosity-dependent injectability evaluation for prefilled syringes, European Journal of Pharmaceutics and Biopharmaceutics. (2024) 19, doi: 10.1016\/j.ejpb.2024.114221.","DOI":"10.1016\/j.ejpb.2024.114221"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114901_b0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.xphs.2019.10.033","article-title":"Assessment of the injection performance of a tapered needle for use in prefilled biopharmaceutical products","volume":"109","author":"Krayukhina","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114901_b0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2015.07.054","article-title":"Calculation of injection forces for highly concentrated protein solutions","volume":"493","author":"Fischer","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114901_b0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejpb.2022.05.009","article-title":"Needle clogging of protein solutions in prefilled syringes: a two-stage process with various determinants","volume":"176","author":"Scheler","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114901_b0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40261-023-01284-5","article-title":"Healthcare professional (HCP) and patient usability evaluation and preferences of two auto-injector devices for self-injection of biosimilars, SB4 and SB5: a literature review","volume":"43","author":"H\u00e9ctor Corominas","year":"2023","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejpb.2025.114901_b0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/IES-2011-0423","article-title":"Age and sex variations of the index finger flexion and extension strength in adult Bengalee population","volume":"19","author":"De","year":"2011","journal-title":"Isokinetics Exercise Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114901_b0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40744-020-00245-0","article-title":"Understanding and minimising injection-site pain following subcutaneous administration of biologics: a narrative review","volume":"7","author":"St Clair-Jones","year":"2020","journal-title":"Rheumatology and Therapy"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114901_b0070","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5731\/pdajpst.2011.00785","article-title":"Variability in syringe components and its impact on functionality of delivery systems","volume":"65","author":"Rathore","year":"2011","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114901_b0075","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1208\/s12249-011-9625-y","article-title":"Injectability evaluation: an open issue","volume":"12","author":"Cilurzo","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2025.114901_b0080","doi-asserted-by":"crossref","unstructured":"Joshua W. Robinson, Yan Zhou, Priyanka Bhattacharya, Robert Erck, Jun Qu JTBLC. Probing the molecular design of hyper-branched aryl polyesters towards lubricant applications. Scientific Reports. 6(18624) (2016) doi:10.1038\/srep18624.","DOI":"10.1038\/srep18624"},{"issue":"12","key":"10.1016\/j.ejpb.2025.114901_b0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/dia.2014.0111","article-title":"Intramuscular risk at insulin injection sites\u2014measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy","volume":"16","author":"Hirsch","year":"2014","journal-title":"Diabetes Technol. Ther."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114901_b0090","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1185\/03007995.2010.481203","article-title":"Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations","volume":"26","author":"Gibney","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"issue":"8","key":"10.1016\/j.ejpb.2025.114901_b0095","first-page":"2","article-title":"Evaluation of skin and subcutaneous adipose tissue thickness for optimal insulin injection","volume":"3","author":"Akkus","year":"2012","journal-title":"J. Diabetesmetab."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114901_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086637","article-title":"Effects of age, gender, BMI, and anatomical site on skin thickness in children and adults with diabetes","volume":"9","author":"Derraik","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejpb.2025.114901_b0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4093\/dmj.2014.38.2.120","article-title":"The appropriateness of the length of insulin needles based on determination of skin and subcutaneous fat thickness in the abdomen and upper arm in patients with type 2 diabetes","volume":"38","author":"Sim","year":"2014","journal-title":"Diabetes Metabolism J."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114901_b0110","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s12325-019-01101-6","article-title":"Subcutaneous injection of drugs: literature review of factors influencing pain sensation at the injection site","volume":"36","author":"Usach","year":"2019","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114901_b0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/2000656X.2015.1111223","article-title":"The importance of needle gauge for pain during injection of lidocaine","volume":"50","author":"W\u00e5g\u00f8","year":"2016","journal-title":"J. Plast. Surg. Hand Surg."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114901_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/08990220600700925","article-title":"Pain following controlled cutaneous insertion of needles with different diameters","volume":"23","author":"Arendt-Nielsen","year":"2006","journal-title":"Somatosens. Mot. Res."},{"issue":"9","key":"10.1016\/j.ejpb.2025.114901_b0125","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1592\/phco.22.13.1105.33510","article-title":"Comparison of two needle sizes for subcutaneous administration of enoxaparin: effects on size of hematomas and pain on injection","volume":"22","author":"Robb","year":"2002","journal-title":"Pharmacotherapy: J. Human Pharmacol. Drug Therapy"},{"issue":"11","key":"10.1016\/j.ejpb.2025.114901_b0130","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.xphs.2022.08.036","article-title":"Advanced formulations\/drug delivery systems for subcutaneous delivery of protein-based biotherapeutics","volume":"111","author":"Lou","year":"2022","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:28:57Z","timestamp":1773185337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125002784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":26,"alternative-id":["S0939641125002784"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114901","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving prefilled syringe injectability: influences of critical component attributes and human factors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114901"}}